Live Q&A: Right Patient, Right Treatment, Right Time: Utilizing Early, High-Efficacy Therapies to Improve Outcomes in RRMS
Recent studies have demonstrated the benefits of early and aggressive treatment strategies in reducing disability progression and the frequency of relapses in patients with relapsing-remitting multiple sclerosis (RRMS), marking a paradigm shift in the treatment of patients with RRMS. The traditional escalation approach is now often set aside in favor of the more individualized “induction” approach, which utilizes “early and aggressive” treatment with high-efficacy disease-modifying therapies (DMTs) to treat patients with high-risk disease.
The induction approach requires selection of DMTs based on disease activity, prognostic factors, and patient characteristics. This is challenging for clinicians due to the expanding treatment landscape for RRMS and the lack of specific guidelines. Additionally, neurologists often lack the knowledge and competence to identify patients who are candidates for this approach.
This live question and answer session is your opportunity to ask questions based on the CME Outfitters virtual symposium where expert faculty focused on the prognostic factors that should be considered when developing treatment plans for patients with MS, as well as the latest clinical data on approved and emerging DMTs. To view the full activity ahead of this live Q&A, click here.Read More
Live Q&A: Keeping the Beat: Screening and Management of High-Risk Patients with Non-Valvular Atrial Fibrillation
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, projected to affect 12 million Americans by 2030. However, a significant number of AF cases, particularly non-valvular atrial fibrillation (NVAF) remain undiagnosed, putting patients at risk for severe cardiovascular (CV) complications, including increased risk of stroke. It is imperative that clinicians identify the symptomatology of AF and effectively diagnose NVAF, as these complications can potentially be avoided by increased screening and guideline-directed anticoagulation treatment. Unfortunately, despite the fact that both opportunistic and systematic screening have been shown to be effective in detecting NVAF, clinicians often lack knowledge of the available tools and strategies for implementing it, particularly in primary care settings.
This live question-and-answer session is your opportunity to ask our faculty your questions based on the CME Outfitters Live webcast that took place on October 7, 2020.Read More
Live Q&A: At-Risk Patients Hidden in Plain Sight: Real-World Strategies for Screening and Treating Hepatitis B Virus
This live question and answer session is your opportunity to ask questions based on the CME Outfitters virtual symposium where expert faculty utilized augmented reality to add visualization to their discussion of how to implement routine screening protocols for HBV in primary care settings, how to optimize the efficacy and safety profiles of current agents, and the importance of providing culturally appropriate counseling and support services to patients, which will ensure understanding of their disease and promote retention in care. To view the full activity ahead of this live Q&A, click here.Read More
This live question and answer session is your opportunity to ask questions of our expert faculty. The original virtual symposium discussed a series of patient cases with the goal of helping clinicians better understand, share, and implement optimal management strategies for IBD. To view the full activity ahead of this live Q&A, click here.Read More